The global insulin delivery device market accounted for revenues of $9.9
billion in 2015, and it is expected to grow at a CAGR of 6.6% during
2016-2022.

Diabetes is a chronic disease caused due to insufficient production or
inappropriate use of insulin in the body. Proper intervention is needed
for diabetes, so as to reduce complications, such as damage of kidney,
eyes, heart and feet, and death. Insulin in delivered with the help of
various delivery devices such as insulin pumps, pen injectors, insulin
syringe and jet injectors. Insulin syringes are most commonly used
delivery system for self-medication. However, insulin syringe not being
a convenient option resulted in development of other devices for the
treatment of diabetes.

The global insulin delivery device market is growing at a significant
rate, due to growing geriatric population, increasing prevalence of
diabetes and increasing prevalence of obesity. In addition, the
technological advancement in the delivery device and increasing
awareness of diabetic care are also driving the growth of the global
market. The increasing awareness of diabetes across the globe through
campaigns, conferences and activities is creating awareness about the
long term effects and complications of diabetes and encourages people to
enter regular diabetes checkups. The restraints associated with the
growth of the global insulin delivery device market include hazards and
risks associated with delivery device and high analogue cost.